Bradmer Pharmaceuticals Inc. Announces Proposed Reverse Take-Over Transaction With XORTX Pharma Corp.
TORONTO, ONTARIO–(Marketwired – Nov. 18, 2014) –
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW.
Bradmer Pharmaceuticals Inc. (“Bradmer”) (TSX VENTURE:BMR.H) announced today that it has entered into a letter of intent (“Letter of Intent”) dated November 18, 2014 with XORTX Pharma Corp.
› Read more